Paradigm Biopharmaceuticals Ltd.ASX: PAR

Published Canine Study Strengthens iPPS Phase 3 Rationale

Feb 11, 2026 at 4:04 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment